Lung Transplantation — LAM-001 in Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome.
Citation(s)
A Randomized, Placebo-controlled Phase 2 Study to Demonstrate the Safety and Efficacy of the Addition of LAM-001 to Standard Immunosuppression Therapy for Chronic Lung Allograft Dysfunction (BOS).